Position in SGMT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,229,927
-$695,655 QoQ
Shares Held
1,000,943
0.0% QoQ
Ownership
1.62%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SGMT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Woodline Partners LP holds $3,316,203,980 across 189 Biotechnology names. SGMT ranks #110 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
2,506,570 | $243,763,932 | |
| 2 | TNGX |
Tango Therapeutics, Inc.
|
8,000,013 | $167,360,271 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
1,414,173 | $149,053,834 | |
| 4 | RCUS |
Arcus Biosciences, Inc.
|
3,777,798 | $81,600,436 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
243,883 | $80,693,568 | |
| 6 | SRRK |
Scholar Rock Holding Corp
|
1,500,470 | $73,763,105 | |
| 7 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
758,891 | $66,000,750 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,000,428 | $65,938,209 |
All Filings in SGMT
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,229,927 | 1,000,943 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,925,582 | 1,000,943 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $10,299,309 | 1,501,357 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $19,450,324 | 2,552,536 | Shares | Sole | 2025-08-14 | |
| 2024-03-31 | $1,626,921 | 300,170 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,626,915 | 300,169 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,641,504 | 300,171 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||